RU2004114875A - Производные дикарбоновых кислот, их получение и терапевтическое применение - Google Patents
Производные дикарбоновых кислот, их получение и терапевтическое применение Download PDFInfo
- Publication number
- RU2004114875A RU2004114875A RU2004114875/04A RU2004114875A RU2004114875A RU 2004114875 A RU2004114875 A RU 2004114875A RU 2004114875/04 A RU2004114875/04 A RU 2004114875/04A RU 2004114875 A RU2004114875 A RU 2004114875A RU 2004114875 A RU2004114875 A RU 2004114875A
- Authority
- RU
- Russia
- Prior art keywords
- phenyl
- methylpent
- ynyl
- pent
- optionally substituted
- Prior art date
Links
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 72
- -1 4- {5- [4- (2-ethoxy-2-ethoxycarbonylethyl) phenoxy] pent-3-en-1-ynyl} phenyl Chemical group 0.000 claims 68
- 229910052736 halogen Inorganic materials 0.000 claims 67
- 125000005843 halogen group Chemical group 0.000 claims 53
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 40
- 150000001875 compounds Chemical class 0.000 claims 33
- 125000000217 alkyl group Chemical group 0.000 claims 32
- 125000001424 substituent group Chemical group 0.000 claims 27
- 125000003545 alkoxy group Chemical group 0.000 claims 26
- 229910052739 hydrogen Inorganic materials 0.000 claims 26
- 150000002367 halogens Chemical class 0.000 claims 19
- 229910052799 carbon Inorganic materials 0.000 claims 18
- 239000000203 mixture Substances 0.000 claims 16
- 125000003118 aryl group Chemical group 0.000 claims 13
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 12
- 125000000732 arylene group Chemical group 0.000 claims 11
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
- UCQVUNUTHKGDJR-UHFFFAOYSA-N 2-ethoxy-2-phenylpropanoic acid Chemical compound CCOC(C)(C(O)=O)C1=CC=CC=C1 UCQVUNUTHKGDJR-UHFFFAOYSA-N 0.000 claims 9
- 125000005336 allyloxy group Chemical group 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 7
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 7
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 6
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 claims 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 6
- 239000005977 Ethylene Substances 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 6
- 125000005366 cycloalkylthio group Chemical group 0.000 claims 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 6
- 125000005549 heteroarylene group Chemical group 0.000 claims 6
- 230000003287 optical effect Effects 0.000 claims 6
- 239000003614 peroxisome proliferator Substances 0.000 claims 6
- 235000019260 propionic acid Nutrition 0.000 claims 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 4
- 208000011580 syndromic disease Diseases 0.000 claims 4
- 201000001320 Atherosclerosis Diseases 0.000 claims 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims 3
- 208000032928 Dyslipidaemia Diseases 0.000 claims 3
- 208000002705 Glucose Intolerance Diseases 0.000 claims 3
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 3
- 108020005497 Nuclear hormone receptor Proteins 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 3
- 102000006255 nuclear receptors Human genes 0.000 claims 3
- 108020004017 nuclear receptors Proteins 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 201000009104 prediabetes syndrome Diseases 0.000 claims 3
- 102000005962 receptors Human genes 0.000 claims 3
- 108020003175 receptors Proteins 0.000 claims 3
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims 2
- WBNNGLSTECFJOB-UHFFFAOYSA-N 3-[4-[3-[4-[4-[4-[4-(2-carboxy-2-ethoxyethyl)phenoxy]but-2-en-2-yl]phenyl]phenyl]but-2-enoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C1=CC=C(C=2C=CC(=CC=2)C(C)=CCOC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 WBNNGLSTECFJOB-UHFFFAOYSA-N 0.000 claims 2
- UTPUMVWOJOGZEJ-UHFFFAOYSA-N 3-[4-[5-[7-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]-9-oxofluoren-2-yl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C#CC1=CC=C(C=2C(=CC(=CC=2)C#CC(C)=CCOC=2C=CC(CC(OCC)C(O)=O)=CC=2)C2=O)C2=C1 UTPUMVWOJOGZEJ-UHFFFAOYSA-N 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000004419 alkynylene group Chemical group 0.000 claims 2
- 125000005724 cycloalkenylene group Chemical group 0.000 claims 2
- 125000002993 cycloalkylene group Chemical group 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims 1
- BHOWJSLAKFIFLM-UHFFFAOYSA-N 2-(2-benzoylanilino)-3-[4-[5-[4-[5-[4-[2-(2-benzoylanilino)-2-carboxyethyl]phenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]propanoic acid Chemical compound C=1C=CC=C(C(=O)C=2C=CC=CC=2)C=1NC(C(=O)O)CC(C=C1)=CC=C1OCC=CC#CC(C=C1)=CC=C1C#CC=CCOC(C=C1)=CC=C1CC(C(O)=O)NC1=CC=CC=C1C(=O)C1=CC=CC=C1 BHOWJSLAKFIFLM-UHFFFAOYSA-N 0.000 claims 1
- FZZCXQUCZGBGHX-UHFFFAOYSA-N 2-[3-[5-[4-[5-[3-(2-ethoxy-2-oxoethyl)phenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]acetic acid Chemical compound CCOC(=O)CC1=CC=CC(OCC=CC#CC=2C=CC(=CC=2)C#CC=CCOC=2C=C(CC(O)=O)C=CC=2)=C1 FZZCXQUCZGBGHX-UHFFFAOYSA-N 0.000 claims 1
- MJUXCMADIDYWNI-UHFFFAOYSA-N 2-[4-[3-[3-[3-[4-(2-methoxy-2-oxoethyl)phenoxy]prop-1-ynyl]phenyl]prop-2-ynoxy]phenyl]acetic acid Chemical compound C1=CC(CC(=O)OC)=CC=C1OCC#CC1=CC=CC(C#CCOC=2C=CC(CC(O)=O)=CC=2)=C1 MJUXCMADIDYWNI-UHFFFAOYSA-N 0.000 claims 1
- HKZFMPNKPKSHEJ-UHFFFAOYSA-N 2-[4-[3-[4-[4-[4-[4-(carboxymethoxy)-3-methylphenyl]sulfanylbut-2-en-2-yl]phenyl]phenyl]but-2-enylsulfanyl]-2-methylphenyl]acetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C(C)=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=CC=1C(C)=CCSC1=CC=C(CC(O)=O)C(C)=C1 HKZFMPNKPKSHEJ-UHFFFAOYSA-N 0.000 claims 1
- XGIZHRCWEIVWOO-UHFFFAOYSA-N 2-[4-[3-[4-[4-[4-[4-(carboxymethyl)-2-chlorophenoxy]but-2-en-2-yl]phenyl]phenyl]but-2-enoxy]-3-chlorophenyl]acetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C(C)=CCOC=2C(=CC(CC(O)=O)=CC=2)Cl)C=CC=1C(C)=CCOC1=CC=C(CC(O)=O)C=C1Cl XGIZHRCWEIVWOO-UHFFFAOYSA-N 0.000 claims 1
- PUVFZEATGUBUAZ-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(OCC=C(C#CC=2C=C(C=CC2)C#CC(=CCOC2=CC=C(C=C2)C(C(=O)O)(C)OCC)C)C)C=C1)OCC PUVFZEATGUBUAZ-UHFFFAOYSA-N 0.000 claims 1
- QWJMWCIAPOFMMP-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(C=C1)SCC=C(C#CC=1C=C(C=CC1)C#CC(=CCOC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)OCC QWJMWCIAPOFMMP-UHFFFAOYSA-N 0.000 claims 1
- AIDSGSJYUUOITO-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(C=C1)SCC=C(C#CC=1C=C(C=CC1)C#CC(=CCSC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)OCC AIDSGSJYUUOITO-UHFFFAOYSA-N 0.000 claims 1
- JLDGRPBLIDIBPF-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanyl-2-methylphenyl]acetic acid Chemical compound C=1C=CC(C#CC(C)=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)=CC=1C#CC(C)=CCSC1=CC=C(CC(O)=O)C(C)=C1 JLDGRPBLIDIBPF-UHFFFAOYSA-N 0.000 claims 1
- AAUYKWOTSSMFME-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)COC1=C(C=C(C=C1)SCC=C(C#CC=1C=C(C=CC1)C#CC(=CCSC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)C AAUYKWOTSSMFME-UHFFFAOYSA-N 0.000 claims 1
- TUEVAUYICVNLHE-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(carboxymethyl)-2-chlorophenoxy]-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]-3-chlorophenyl]acetic acid Chemical compound C=1C=CC(C#CC(C)=CCOC=2C(=CC(CC(O)=O)=CC=2)Cl)=CC=1C#CC(C)=CCOC1=CC=C(CC(O)=O)C=C1Cl TUEVAUYICVNLHE-UHFFFAOYSA-N 0.000 claims 1
- RUUYBSUGPKIZTP-UHFFFAOYSA-N 2-[4-[5-[3-[5-[4-(carboxymethyl)-2-chlorophenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]-3-chlorophenyl]acetic acid Chemical compound ClC1=CC(CC(=O)O)=CC=C1OCC=CC#CC1=CC=CC(C#CC=CCOC=2C(=CC(CC(O)=O)=CC=2)Cl)=C1 RUUYBSUGPKIZTP-UHFFFAOYSA-N 0.000 claims 1
- AMKBRZNSQOOHBJ-UHFFFAOYSA-N 2-[4-[5-[4-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]phenyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(OCC=C(C#CC2=CC=C(C=C2)C2=CC=C(C=C2)C#CC(=CCOC2=CC=C(C=C2)C(C(=O)O)(C)OCC)C)C)C=C1)OCC AMKBRZNSQOOHBJ-UHFFFAOYSA-N 0.000 claims 1
- NTQYBNFPDKDRCE-UHFFFAOYSA-N 2-[4-[5-[4-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(C=C1)SCC=C(C#CC1=CC=C(C=C1)C1=CC=C(C=C1)C#CC(=CCOC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)OCC NTQYBNFPDKDRCE-UHFFFAOYSA-N 0.000 claims 1
- VWLGCSUHALBVMX-UHFFFAOYSA-N 2-[4-[5-[4-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(C=C1)SCC=C(C#CC1=CC=C(C=C1)C1=CC=C(C=C1)C#CC(=CCSC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)OCC VWLGCSUHALBVMX-UHFFFAOYSA-N 0.000 claims 1
- KOZLTKXZTIBFPO-UHFFFAOYSA-N 2-[4-[5-[4-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanyl-2-methylphenyl]acetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C#CC(C)=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=CC=1C#CC(C)=CCSC1=CC=C(CC(O)=O)C(C)=C1 KOZLTKXZTIBFPO-UHFFFAOYSA-N 0.000 claims 1
- ZHLFLHHKMQFEJB-UHFFFAOYSA-N 2-[4-[5-[4-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)COC1=C(C=C(C=C1)SCC=C(C#CC1=CC=C(C=C1)C1=CC=C(C=C1)C#CC(=CCSC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)C ZHLFLHHKMQFEJB-UHFFFAOYSA-N 0.000 claims 1
- OWTIKXUBXJGGOL-UHFFFAOYSA-N 2-[4-[5-[4-[4-[5-[4-(carboxymethyl)-2-chlorophenoxy]-3-methylpent-3-en-1-ynyl]phenyl]phenyl]-3-methylpent-2-en-4-ynoxy]-3-chlorophenyl]acetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C#CC(C)=CCOC=2C(=CC(CC(O)=O)=CC=2)Cl)C=CC=1C#CC(C)=CCOC1=CC=C(CC(O)=O)C=C1Cl OWTIKXUBXJGGOL-UHFFFAOYSA-N 0.000 claims 1
- IFEKJQTWUUOPAS-UHFFFAOYSA-N 2-[4-[5-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(OCC=C(C#CC2=CC=C(C=C2)C#CC(=CCOC2=CC=C(C=C2)C(C(=O)O)(C)OCC)C)C)C=C1)OCC IFEKJQTWUUOPAS-UHFFFAOYSA-N 0.000 claims 1
- QXHYZYKHNWYHQK-UHFFFAOYSA-N 2-[4-[5-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(C=C1)SCC=C(C#CC1=CC=C(C=C1)C#CC(=CCOC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)OCC QXHYZYKHNWYHQK-UHFFFAOYSA-N 0.000 claims 1
- AOLFURDLRCHXAH-UHFFFAOYSA-N 2-[4-[5-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C(=O)(O)C(CC1=CC=C(C=C1)SCC=C(C#CC1=CC=C(C=C1)C#CC(=CCSC1=CC=C(C=C1)C(C(=O)O)(C)OCC)C)C)OCC AOLFURDLRCHXAH-UHFFFAOYSA-N 0.000 claims 1
- JZAWFMKYEBDTTA-UHFFFAOYSA-N 2-[4-[5-[4-[5-[4-(2-methoxy-2-oxoethoxy)-3-methylphenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]-2-methylphenoxy]acetic acid Chemical compound C1=C(C)C(OCC(=O)OC)=CC=C1OCC=CC#CC1=CC=C(C#CC=CCOC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 JZAWFMKYEBDTTA-UHFFFAOYSA-N 0.000 claims 1
- CWBJXYVTWCDXHE-UHFFFAOYSA-N 2-[4-[5-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynyl]sulfanyl-2-methylphenyl]acetic acid Chemical compound C=1C=C(C#CC(C)=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=CC=1C#CC(C)=CCSC1=CC=C(CC(O)=O)C(C)=C1 CWBJXYVTWCDXHE-UHFFFAOYSA-N 0.000 claims 1
- QLIKGGBUHSWGGF-UHFFFAOYSA-N 2-[4-[5-[4-[5-[4-(carboxymethyl)-3-chlorophenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]-3-chlorophenyl]acetic acid Chemical compound ClC1=CC(CC(=O)O)=CC=C1OCC=CC#CC1=CC=C(C#CC=CCOC=2C=C(Cl)C(CC(O)=O)=CC=2)C=C1 QLIKGGBUHSWGGF-UHFFFAOYSA-N 0.000 claims 1
- XWAVVQXAJZJKJM-UHFFFAOYSA-N 2-[4-[5-[7-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]-9-oxofluoren-2-yl]-3-methylpent-2-en-4-ynyl]sulfanyl-2-methylphenoxy]acetic acid Chemical compound C=1C=C(C2=CC=C(C=C2C2=O)C#CC(C)=CCSC=3C=C(C)C(OCC(O)=O)=CC=3)C2=CC=1C#CC(C)=CCSC1=CC=C(OCC(O)=O)C(C)=C1 XWAVVQXAJZJKJM-UHFFFAOYSA-N 0.000 claims 1
- QHUVNZWSRBHWPN-UHFFFAOYSA-N 2-[4-[5-[7-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanyl-3-methylpent-3-en-1-ynyl]-9h-carbazol-2-yl]-3-methylpent-2-en-4-ynyl]sulfanyl-2-methylphenoxy]acetic acid Chemical compound C=1C=C(C2=CC=C(C=C2N2)C#CC(C)=CCSC=3C=C(C)C(OCC(O)=O)=CC=3)C2=CC=1C#CC(C)=CCSC1=CC=C(OCC(O)=O)C(C)=C1 QHUVNZWSRBHWPN-UHFFFAOYSA-N 0.000 claims 1
- DNHUVSFXLIJVBT-UHFFFAOYSA-N 3-[3-bromo-4-[5-[4-[5-[2-bromo-4-(2,3-diethoxy-3-oxopropyl)phenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound BrC1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=C(C#CC=CCOC=2C(=CC(CC(OCC)C(=O)OCC)=CC=2)Br)C=C1 DNHUVSFXLIJVBT-UHFFFAOYSA-N 0.000 claims 1
- GTGLNACSGLRJKF-UHFFFAOYSA-N 3-[4-[3-[4-[4-[4-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanylbut-2-en-2-yl]phenyl]phenyl]but-2-enoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C1=CC=C(C=2C=CC(=CC=2)C(C)=CCSC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 GTGLNACSGLRJKF-UHFFFAOYSA-N 0.000 claims 1
- CGQFHCSVHQXMGE-UHFFFAOYSA-N 3-[4-[3-[4-[4-[4-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanylbut-2-en-2-yl]phenyl]phenyl]but-2-enylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=C(C)C1=CC=C(C=2C=CC(=CC=2)C(C)=CCSC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 CGQFHCSVHQXMGE-UHFFFAOYSA-N 0.000 claims 1
- QMJIUGQLLMFEJB-UHFFFAOYSA-N 3-[4-[3-[4-[4-[4-[4-(carboxymethoxy)-3-methylphenyl]sulfanylbut-2-en-2-yl]phenyl]phenyl]but-2-enoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C1=CC=C(C=2C=CC(=CC=2)C(C)=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 QMJIUGQLLMFEJB-UHFFFAOYSA-N 0.000 claims 1
- YMJDOCQKCFJSNK-UHFFFAOYSA-N 3-[4-[3-[4-[4-[4-[4-(carboxymethoxy)-3-methylphenyl]sulfanylbut-2-en-2-yl]phenyl]phenyl]but-2-enylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=C(C)C1=CC=C(C=2C=CC(=CC=2)C(C)=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 YMJDOCQKCFJSNK-UHFFFAOYSA-N 0.000 claims 1
- XSISCPYJHDFYSO-UHFFFAOYSA-N 3-[4-[5-[3-[5-[4-(2,3-diethoxy-3-oxopropyl)phenoxy]-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C#CC1=CC=CC(C#CC(C)=CCOC=2C=CC(CC(OCC)C(=O)OCC)=CC=2)=C1 XSISCPYJHDFYSO-UHFFFAOYSA-N 0.000 claims 1
- LMKKIEZOWSKCSP-UHFFFAOYSA-N 3-[4-[5-[3-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=CC(C#CC=CCOC=2C=CC(CC(OCC)C(O)=O)=CC=2)=C1 LMKKIEZOWSKCSP-UHFFFAOYSA-N 0.000 claims 1
- GATZGZSHRIQEQK-UHFFFAOYSA-N 3-[4-[5-[3-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanylpent-3-en-1-ynyl]phenyl]pent-2-en-4-ynylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=CC#CC1=CC=CC(C#CC=CCSC=2C=CC(CC(OCC)C(O)=O)=CC=2)=C1 GATZGZSHRIQEQK-UHFFFAOYSA-N 0.000 claims 1
- CPJNYZGVVLVQSV-UHFFFAOYSA-N 3-[4-[5-[3-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanylpent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=CC(C#CC=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)=C1 CPJNYZGVVLVQSV-UHFFFAOYSA-N 0.000 claims 1
- KDAFGSBMNWXPHG-UHFFFAOYSA-N 3-[4-[5-[3-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanylpent-3-en-1-ynyl]phenyl]pent-2-en-4-ynylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=CC#CC1=CC=CC(C#CC=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)=C1 KDAFGSBMNWXPHG-UHFFFAOYSA-N 0.000 claims 1
- IBQTTYMWGHHIET-UHFFFAOYSA-N 3-[4-[5-[4-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]pent-3-en-1-ynyl]phenyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=C(C=2C=CC(=CC=2)C#CC=CCOC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 IBQTTYMWGHHIET-UHFFFAOYSA-N 0.000 claims 1
- GGGFPQBQISOYSE-UHFFFAOYSA-N 3-[4-[5-[4-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanylpent-3-en-1-ynyl]phenyl]phenyl]pent-2-en-4-ynylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=CC#CC1=CC=C(C=2C=CC(=CC=2)C#CC=CCSC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 GGGFPQBQISOYSE-UHFFFAOYSA-N 0.000 claims 1
- WCSUANXLXLORFD-UHFFFAOYSA-N 3-[4-[5-[4-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanylpent-3-en-1-ynyl]phenyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=C(C=2C=CC(=CC=2)C#CC=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 WCSUANXLXLORFD-UHFFFAOYSA-N 0.000 claims 1
- GPKRKCHDDYZQPR-UHFFFAOYSA-N 3-[4-[5-[4-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanylpent-3-en-1-ynyl]phenyl]phenyl]pent-2-en-4-ynylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=CC#CC1=CC=C(C=2C=CC(=CC=2)C#CC=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 GPKRKCHDDYZQPR-UHFFFAOYSA-N 0.000 claims 1
- DONNNMTWKHKHJE-UHFFFAOYSA-N 3-[4-[5-[4-[5-[4-(2,3-diethoxy-3-oxopropyl)phenoxy]-3-methylpent-3-en-1-ynyl]phenyl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C#CC1=CC=C(C#CC(C)=CCOC=2C=CC(CC(OCC)C(=O)OCC)=CC=2)C=C1 DONNNMTWKHKHJE-UHFFFAOYSA-N 0.000 claims 1
- PPRHTQAPLDSYQI-UHFFFAOYSA-N 3-[4-[5-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=C(C#CC=CCOC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 PPRHTQAPLDSYQI-UHFFFAOYSA-N 0.000 claims 1
- MYIBIHBLROIABM-UHFFFAOYSA-N 3-[4-[5-[4-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanylpent-3-en-1-ynyl]phenyl]pent-2-en-4-ynylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=CC#CC1=CC=C(C#CC=CCSC=2C=CC(CC(OCC)C(O)=O)=CC=2)C=C1 MYIBIHBLROIABM-UHFFFAOYSA-N 0.000 claims 1
- SDESQGUZSQRHIV-UHFFFAOYSA-N 3-[4-[5-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanylpent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=C(C#CC=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 SDESQGUZSQRHIV-UHFFFAOYSA-N 0.000 claims 1
- ARCOOJATRXPAOG-UHFFFAOYSA-N 3-[4-[5-[4-[5-[4-(carboxymethoxy)-3-methylphenyl]sulfanylpent-3-en-1-ynyl]phenyl]pent-2-en-4-ynylsulfanyl]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=CC#CC1=CC=C(C#CC=CCSC=2C=C(C)C(OCC(O)=O)=CC=2)C=C1 ARCOOJATRXPAOG-UHFFFAOYSA-N 0.000 claims 1
- MPOCMEXRFDUBBJ-UHFFFAOYSA-N 3-[4-[5-[7-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]-9-oxofluoren-2-yl]pent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=CC#CC1=CC=C(C=2C(=CC(=CC=2)C#CC(C)=CCOC=2C=CC(CC(OCC)C(O)=O)=CC=2)C2=O)C2=C1 MPOCMEXRFDUBBJ-UHFFFAOYSA-N 0.000 claims 1
- ITUHWOYFKZXDHG-UHFFFAOYSA-N 3-[4-[5-[7-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]-9h-carbazol-2-yl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C#CC1=CC=C2C3=CC=C(C#CC(C)=CCOC=4C=CC(CC(OCC)C(O)=O)=CC=4)C=C3NC2=C1 ITUHWOYFKZXDHG-UHFFFAOYSA-N 0.000 claims 1
- SYHLHYDHUQLNMZ-UHFFFAOYSA-N 3-[4-[5-[7-[5-[4-(2-carboxy-2-ethoxyethyl)phenoxy]-3-methylpent-3-en-1-ynyl]-9h-fluoren-2-yl]-3-methylpent-2-en-4-ynoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC=C(C)C#CC1=CC=C2C3=CC=C(C#CC(C)=CCOC=4C=CC(CC(OCC)C(O)=O)=CC=4)C=C3CC2=C1 SYHLHYDHUQLNMZ-UHFFFAOYSA-N 0.000 claims 1
- AYJFZNNHQZPSQW-UHFFFAOYSA-N 3-[4-[5-[7-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]-9H-carbazol-2-yl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=C(C)C#CC1=CC=C2C3=CC=C(C#CC(C)=CCSC=4C=CC(CC(OCC)C(O)=O)=CC=4)C=C3NC2=C1 AYJFZNNHQZPSQW-UHFFFAOYSA-N 0.000 claims 1
- UXPHAGNBAZSDBK-UHFFFAOYSA-N 3-[4-[5-[7-[5-[4-(2-carboxy-2-ethoxyethyl)phenyl]sulfanyl-3-methylpent-3-en-1-ynyl]-9H-fluoren-2-yl]-3-methylpent-2-en-4-ynyl]sulfanylphenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1SCC=C(C)C#CC1=CC=C2C3=CC=C(C#CC(C)=CCSC=4C=CC(CC(OCC)C(O)=O)=CC=4)C=C3CC2=C1 UXPHAGNBAZSDBK-UHFFFAOYSA-N 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- LMBCWHWDEHGPPP-UHFFFAOYSA-N ethyl 2-[3-[5-[4-[5-[3-(2-ethoxy-2-oxoethyl)phenoxy]pent-3-en-1-ynyl]phenyl]pent-2-en-4-ynoxy]phenyl]acetate Chemical compound CCOC(=O)CC1=CC=CC(OCC=CC#CC=2C=CC(=CC=2)C#CC=CCOC=2C=C(CC(=O)OCC)C=CC=2)=C1 LMBCWHWDEHGPPP-UHFFFAOYSA-N 0.000 claims 1
- NHHPYFYSDKUBBA-UHFFFAOYSA-N methyl 2-[4-[3-[3-[3-[4-(2-methoxy-2-oxoethyl)phenoxy]prop-1-ynyl]phenyl]prop-2-ynoxy]phenyl]acetate Chemical compound C1=CC(CC(=O)OC)=CC=C1OCC#CC1=CC=CC(C#CCOC=2C=CC(CC(=O)OC)=CC=2)=C1 NHHPYFYSDKUBBA-UHFFFAOYSA-N 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- DLRJIFUOBPOJNS-UHFFFAOYSA-N phenetole Chemical compound CCOC1=CC=CC=C1 DLRJIFUOBPOJNS-UHFFFAOYSA-N 0.000 claims 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101524 | 2001-10-17 | ||
| DKPA200101524 | 2001-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2004114875A true RU2004114875A (ru) | 2005-09-10 |
Family
ID=8160773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004114875/04A RU2004114875A (ru) | 2001-10-17 | 2002-10-15 | Производные дикарбоновых кислот, их получение и терапевтическое применение |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1438283A1 (enExample) |
| JP (1) | JP2005505616A (enExample) |
| KR (1) | KR20050036876A (enExample) |
| CN (1) | CN1571766A (enExample) |
| BR (1) | BR0213253A (enExample) |
| CA (1) | CA2462514A1 (enExample) |
| HU (1) | HUP0401837A2 (enExample) |
| IL (1) | IL161170A0 (enExample) |
| PL (1) | PL370244A1 (enExample) |
| RU (1) | RU2004114875A (enExample) |
| WO (1) | WO2003033453A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2499380A1 (en) * | 2002-09-05 | 2004-03-18 | Novo Nordisk A/S | Novel vinyl carboxylic acid derivatives and their therapeutical use |
| US20050080115A1 (en) | 2002-10-28 | 2005-04-14 | Lone Jeppesen | Novel compounds, their preparation and use |
| DE60332860D1 (de) * | 2002-10-28 | 2010-07-15 | High Point Pharmaceuticals Llc | Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen |
| AU2003287912A1 (en) * | 2002-12-20 | 2004-07-14 | Novo Nordisk A/S | Dicarboxylic acid derivatives as ppar-agonists |
| US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
| FR2850969B1 (fr) * | 2003-02-12 | 2005-03-25 | Genfit S A | Aminopropanediols acyles et analogues et leurs utilisations therapeutiques |
| US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
| ES2352085T3 (es) | 2004-05-05 | 2011-02-15 | High Point Pharmaceuticals, Llc | Nuevos compuestos, su preparación y uso. |
| EP1632245A1 (en) * | 2004-09-02 | 2006-03-08 | Technische Universität Dresden Medizinische Fakultät Carl Gustav Carus | ICA512 couples insulin secretion and gene expression in Beta-cells |
| ES2372617T3 (es) | 2005-06-30 | 2012-01-24 | High Point Pharmaceuticals, Llc | Ácidos fenoxiacéticos como activadores de ppar-delta. |
| EA201101085A1 (ru) | 2005-12-22 | 2012-05-30 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Феноксиуксусные кислоты в качестве активаторов ppar дельта |
| EP1999098A2 (en) * | 2006-03-09 | 2008-12-10 | High Point Pharmaceuticals, LLC | Compounds that modulate ppar activity, their preparation and use |
| WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US8410284B2 (en) | 2008-10-22 | 2013-04-02 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| WO2010051206A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| JP2013520502A (ja) | 2010-02-25 | 2013-06-06 | メルク・シャープ・エンド・ドーム・コーポレイション | 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体 |
| WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2826649C (en) | 2011-02-25 | 2016-07-26 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| US20150004144A1 (en) | 2011-12-02 | 2015-01-01 | The General Hospital Corporation | Differentiation into brown adipocytes |
| US20140045746A1 (en) | 2012-08-02 | 2014-02-13 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| JP2016516004A (ja) | 2013-02-22 | 2016-06-02 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 抗糖尿病二環式化合物 |
| WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| PL3004138T3 (pl) | 2013-06-05 | 2024-07-29 | Bausch Health Ireland Limited | Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2018106518A1 (en) | 2016-12-06 | 2018-06-14 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| WO2018118670A1 (en) | 2016-12-20 | 2018-06-28 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
| CN109200043A (zh) * | 2018-10-23 | 2019-01-15 | 华南农业大学 | 二羧酸（盐）在降低脂肪沉积和预防肥胖方面的应用 |
| CA3185909A1 (en) | 2020-07-22 | 2022-01-27 | Reneo Pharmaceuticals, Inc. | Crystalline ppar-delta agonist |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
| CN116003245B (zh) * | 2022-12-21 | 2026-03-27 | 山东瑞健生物医药科技有限公司 | 一种2-羟基-3-氧代戊烷二酸的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2331336A1 (fr) * | 1975-11-14 | 1977-06-10 | Rolland Sa A | Acides oxy-4,4' bis(phenoxy-2 alcanocarboxyliques), leurs derives et leur application comme medicament |
| US5508296A (en) * | 1991-07-30 | 1996-04-16 | Yamanouchi Pharmaceutical Co., Ltd. | Bisheterocyclic derivative or salt thereof |
| KR20020070508A (ko) * | 2000-01-28 | 2002-09-09 | 노보 노르디스크 에이/에스 | 프로피온산 유도체 및 당뇨병 및 비만의 치료에 그것의 사용 |
| PL357017A1 (en) * | 2000-01-28 | 2004-07-12 | Novo Nordisk A/S | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
-
2002
- 2002-10-15 KR KR1020047005711A patent/KR20050036876A/ko not_active Withdrawn
- 2002-10-15 JP JP2003536195A patent/JP2005505616A/ja not_active Withdrawn
- 2002-10-15 EP EP02772084A patent/EP1438283A1/en not_active Withdrawn
- 2002-10-15 IL IL16117002A patent/IL161170A0/xx unknown
- 2002-10-15 RU RU2004114875/04A patent/RU2004114875A/ru not_active Application Discontinuation
- 2002-10-15 HU HU0401837A patent/HUP0401837A2/hu unknown
- 2002-10-15 WO PCT/DK2002/000692 patent/WO2003033453A1/en not_active Ceased
- 2002-10-15 CN CNA028205472A patent/CN1571766A/zh active Pending
- 2002-10-15 CA CA002462514A patent/CA2462514A1/en not_active Abandoned
- 2002-10-15 PL PL02370244A patent/PL370244A1/xx not_active Application Discontinuation
- 2002-10-15 BR BR0213253-2A patent/BR0213253A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003033453A1 (en) | 2003-04-24 |
| CN1571766A (zh) | 2005-01-26 |
| PL370244A1 (en) | 2005-05-16 |
| IL161170A0 (en) | 2004-08-31 |
| BR0213253A (pt) | 2004-10-26 |
| JP2005505616A (ja) | 2005-02-24 |
| KR20050036876A (ko) | 2005-04-20 |
| HUP0401837A2 (hu) | 2004-12-28 |
| CA2462514A1 (en) | 2003-04-24 |
| EP1438283A1 (en) | 2004-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005505616A5 (enExample) | ||
| RU2312106C2 (ru) | Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar | |
| ZA200100983B (en) | Substituted oxazoles and thiazoles derivatives as hPPAR gamma and hPPAR alpha activators. | |
| RU2404178C2 (ru) | Новые производные тиофена в качестве агонистов рецептора сфингозин-1-фосфата-1 | |
| RU2437877C2 (ru) | Новые производные тиофена в качестве агонистов рецептора s1p1/edg1 | |
| JP2005502600A5 (enExample) | ||
| RU2003134150A (ru) | Замещенные карбоновыми кислотами оксазоловые производные в качестве ppar-альфа и гамма-активаторов при лечении диабета | |
| RU2001131111A (ru) | Новые соединения, их получение и применение | |
| US20090156681A1 (en) | Compounds for the treatment of metabolic disorders | |
| RU2004105956A (ru) | Новые производные винилкарбоновых кислот и их применение в качестве антидиабетических средств и т.п. | |
| RU2005128501A (ru) | Соединение для лечения метаболических расстройств | |
| JP2009528375A5 (enExample) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| RU2004136979A (ru) | (имидазол-1-илметил)пиридазин в качестве блокатора nmda рецептора | |
| JP2004520377A5 (enExample) | ||
| WO2004063165A1 (en) | A pyrazole derivative as ppar modulator | |
| CN1030195C (zh) | 降血糖药噻唑烷二酮及其中间体的制备方法 | |
| RU2005125284A (ru) | Производные 2-пиперидона в качестве агонистов простагландина | |
| HUP0401837A2 (hu) | Dikarbonsavszármazékok, előállításuk és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| RU2008123000A (ru) | Соединения для лечения метаболических нарушений | |
| RU2006108572A (ru) | Соединения для лечения метаболических нарушений | |
| CN1159305C (zh) | 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 | |
| RU2005109163A (ru) | НОВЫЕ СОЕДИНЕНИЯ 2-АРИЛТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ PPARα И PPARγ | |
| US5482971A (en) | Beta3 -adrenergic agents and their use in pharmaceutical compositions | |
| US5480908A (en) | β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20060201 |